Dr. Kocoglu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
22 S Greene St
Baltimore, MD 21201- Is this information wrong?
Education & Training
Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2010 - 2013
University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Internal Medicine, 2003 - 2006- University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Internal Medicine, 1999 - 1999
Hacettepe University FOMClass of 1996
Certifications & Licensure
MD State Medical License 2014 - 2024
CT State Medical License 2010 - 2015
AR State Medical License 2006 - 2011
Publications & Presentations
PubMed
- Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium.Aimaz Afrough, Hamza Hashmi, Doris K Hansen, Surbhi Sidana, Chul Ahn, Lauren C Peres, Danai Dima, Ciara L Freeman, Omar Castaneda Puglianini, Mehmet H Kocoglu, Shebli ...> ;Blood Cancer Journal. 2024 Apr 12
- Defibrotide improves COVID-19-related acute respiratory distress syndrome in myeloma patients after chimeric antigen receptor T-cell treatment without compromising vir...Kocoglu, M., Richardson, P., Mo, C., Rapoport, A., Atanackovic, D.> ;Haematologica. 2024 Feb 22
- A novel multicolor fluorescent spot assay for the functional assessment of chimeric antigen receptor (CAR) T-cell products.Djordje Atanackovic, Thierry Iraguha, Destiny Omili, Stephanie V Avila, Xiaoxuan Fan, Mehmet Kocoglu, Etse Gebru, Jillian M Baker, Nishanthini Dishanthan, Kenneth A Di...> ;Cytotherapy. 2024 Apr 1
- Join now to see all
Abstracts/Posters
- Increased Cortical Glycolysis Following CD19 CART Therapy: A Radiographic Surrogate for an Altered Blood-Brain BarrierMehmet Hakan Kocoglu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) after CD19-Directed Chimeric Antigen Receptor T-Cell Therapy (CAR-T) for Large B-Cell Lymphoma: Predicti...Mehmet Hakan Kocoglu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Hospital Affiliations
University of Maryland Medical CenterBaltimore, Maryland
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
